CRIS Current Research Information System

MONGIORGI, SARA

MONGIORGI, SARA  

DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE  

Personale tecnico amm.vo  

Mostra records
Risultati 1 - 20 di 71 (tempo di esecuzione: 0.034 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes Mongiorgi, Sara; De Stefano, Alessia; Ratti, Stefano; Indio, Valentina; Astolfi, Annalisa; Casali...n, Irene; Pellagatti, Andrea; Paolini, Stefania; Parisi, Sarah; Cavo, Michele; Pession, Andrea; McCubrey, James A; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio; Follo, Matilde Y 2023-01-01 CLINICAL EPIGENETICS - 1.01 Articolo in rivista -
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Man...zoli L.; Finelli C.; Cocco L. 2012-01-01 LEUKEMIA - 1.01 Articolo in rivista -
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes Cocco, Lucio; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Russo, Domenico; Bosi, Costanza;... Quaranta, Marilisa; Malagola, Michele; Parisi, Sarah; Stanzani, Marta; Ramazzotti, Giulia; Mariani, Giulia A.; Billi, Anna Maria; Manzoli, Lucia; Follo, Matilde Y. 2015-01-01 JOURNAL OF LEUKOCYTE BIOLOGY - 1.01 Articolo in rivista -
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C;
Mongiorgi S; Parisi S; Bosi C; ...Manzoli L; Martinelli G; Cocco L;
Baccarani M 		2011-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S;
Papayannidis C; Mongiorgi S; Parisi ...S; Abbenante MC; Bosi C;
Manzoli L; Martinelli G; Cocco L; Cavo M 		2013-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients Carlo Finelli; Cristina Clissa; Maria Teresa Voso; Maria Antonietta Aloe Spiriti; Massimo Breccia...; Gianluca Gaidano; Monica Crugnola; Maria Benedetta Giannini; Costanza Bosi; Virginia Naso; Matilde Y Follo; Sara Mongiorgi; Giovanni Martinelli; Lucio Cocco; Michele Baccarani 2012-01-01 BLOOD - 4.02 Riassunto (Abstract) -
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS Clissa C; Finelli C; Follo MY; Curti A; Paolini S; Papayannidis C;
Mongiorgi S; Parisi S; Abbenan...te MC; Bosi C; Manzoli L;
Martinelli G; Cocco L; Baccarani M 		2012-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes Ratti S.; Rusciano I.; Mongiorgi S.; Owusu Obeng E.; Cappellini A.; Teti G.; Falconi M.; Talozzi ...L.; Capellari S.; Bartoletti-Stella A.; Guaraldi P.; Cortelli P.; Suh P.-G.; Cocco L.; Manzoli L.; Ramazzotti G. 2021-01-01 CELLULAR AND MOLECULAR LIFE SCIENCES - 1.01 Articolo in rivista s00018-020-03661-1.pdf
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia Parisi S.; Finelli C.; Fazio A.; De Stefano A.; Mongiorgi S.; Ratti S.; Cappellini A.; Billi A.M....; Cocco L.; Follo M.Y.; Manzoli L. 2021-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-22-00827-v2.pdf
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes Finelli, Carlo; Follo, Matilde Y; Stanzani, Marta; Parisi, Sarah; Clissa, Cristina; Mongiorgi, Sa...ra; Barraco, Marilena; Cocco, Lucio 2016-01-01 CURRENT PHARMACEUTICAL DESIGN - 1.01 Articolo in rivista -
CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE Follo MY; Clissa C; Mongiorgi S; Stoyanova M; Paolini S; Quaranta
M; Stanzani M; Martinelli G; Ma...nzoli L; Cocco L; Finelli C 		2013-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide M.Y. Follo; S. Mongiorgi; C. Clissa; M. Stoyanova; S. Paolini; M. Quaranta; G. Martinelli; L. Man...zoli; C. Cocco; C. Finelli 2013-01-01 LEUKEMIA RESEARCH - 4.01 Contributo in Atti di convegno -
Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q) Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carmen Baldazzi; Marta Stanzani;... Michele Baccarani; Lucio Cocco 2013-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
Current therapy and new drugs: A road to personalized treatment of myelodysplastic syndromes Parisi S.; Ratti S.; Mongiorgi S.; Suh P.-G.; Manzoli L.; McCubrey J.A.; Cocco L.; Follo M.Y.; Fi...nelli C. 2018-01-01 EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT - 1.01 Articolo in rivista -
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES Follo, My; Mongiorgi, S; Clissa, C; Stanzani, M; Poli, A; Lonetti, A; Cappellini, A; Manzoli, L; ...Cocco L, 1; Finelli, C 2014-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carla Filì; Costanza Bosi; Maril...isa Quaranta; Stefania Paolini; Anna Maria Billi; Marco Gobbi; Michele Baccarani; Domenico Russo; Giovanni Martinelli; Lucia Manzoli; Lucio Cocco 2012-01-01 BLOOD - 4.02 Riassunto (Abstract) -
Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients M.Y. Follo; S. Mongiorgi; C. Clissa; C. Filì; C. Colombi; M. Baccarani; G. Martinelli; M. Gobbi; ...L. Manzoli; D. Russo; C. Finelli; L. Cocco 2011-01-01 LEUKEMIA RESEARCH - 4.01 Contributo in Atti di convegno -
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele B...accarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco 2009-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
EFFECT OF LENALIDOMIDE ON INOSITIDE-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS Follo MY;Mongiorgi S; Clissa C; Baccarani M; Paolini S;
Martinelli G; Manzoli L; Finelli C; Cocco L 		2011-01-01 HAEMATOLOGICA - 4.01 Contributo in Atti di convegno -
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni... Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco 2011-01-01 BLOOD - 4.01 Contributo in Atti di convegno -